Press "Enter" to skip to content

FDA takes new enforcement actions as part of the agency’s ongoing effort to combat the illegal online sales of opioids

Agency issued two warning letters to operators of websites that illegally market potentially dangerous, unapproved and misbranded opioid medications.

Original source:

Also Read:   FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy